Drug intelligence / Profile preview

金口馨复方氯己定含漱液

Development stage: Unknown
Lead developer: Chenpai Bond Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

金口馨复方氯己定含漱液 (Jinkouxin Compound Chlorhexidine Mouthwash) is a pharmaceutical oral rinse approved in China for the auxiliary treatment of various oral inflammatory conditions. It is a combination drug containing chlorhexidine gluconate, an antiseptic that disrupts bacterial cell membranes, and metronidazole, an antibiotic effective against anaerobic bacteria. This combination works to reduce bacterial load and inflammation, providing relief and promoting healing for conditions such as gingivitis, pericoronitis, oral mucositis, gingival bleeding, periodontal abscess, and oral mucosal ulcers. It is manufactured by Jiangsu Chenpai Bond Pharmaceutical Co., Ltd.

Brand names: 金口馨
Other names: 复方氯己定含漱液Jinkouxin Compound Chlorhexidine MouthwashCompound Chlorhexidine Mouthwash

Targets

Neuraminidase

Beyond the preview

Go deeper on 金口馨复方氯己定含漱液.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 金口馨复方氯己定含漱液.

Explore the full profile